US Government to Buy Additional 100 Million Doses of Moderna’s mRNA-1273
Posted on 12/11/2020
Moderna, Inc. is a biotechnology company using messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients. Moderna announced that the U.S. government has exercised its option to purchase an additional 100 million doses of mRNA-1273, Moderna’s COVID-19 vaccine candidate, bringing its confirmed order commitment to 200 million doses. mRNA-1273 is an mRNA vaccine against COVID-19 encoding for a prefusion stabilized form of the Spike (S) protein, which was co-developed by Moderna and investigators from NIAID’s Vaccine Research Center.
Of the first 100 million doses purchased by the U.S. government, approximately 20 million doses will be delivered by the end of December 2020 and the balance will be delivered in the first quarter of 2021. The December 11, 2020 new order of 100 million doses will be delivered in the second quarter of 2021. These deliveries are subject, in each case, to receipt of an Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for the vaccine.
Under the terms of the agreement, Moderna will continue to leverage the Company’s U.S.-based manufacturing infrastructure to supply mRNA-1273 to the U.S. government. As part of Operation Warp Speed, the U.S. government has the option to purchase up to an additional 300 million doses of mRNA-1273 from Moderna. The Company expects the U.S. government will provide the vaccine to Americans at no cost as previously announced.
Moderna’s COVID-19 Vaccine Supply Agreements
Moderna has confirmed the following supply agreements of committed orders totaling more than 390 million doses:
United States: 200 million doses with option for an additional 300 million doses
European Union: 80 million doses with option for an additional 80 million doses
Japan: 50 million doses
Canada: 40 million doses with option for an additional 16 million doses
Switzerland: 7.5 million doses
United Kingdom: 7 million doses
Israel: 6 million doses
Qatar
Other countries, which have placed orders and have not been disclosed.
